RecruitingNot Applicable

Development and Evaluation of an Online Shared Decision-Making Educational Program for Nurses and Patients With Chronic Diseases

South Korea288 participantsStarted 2026-05-10

Plain-language summary

This study aims to develop and evaluate an online shared decision-making (SDM) educational program for nurses and patients with chronic diseases. Shared decision-making is a process in which healthcare professionals and patients make health-related decisions together based on the best available evidence and the patient's values and preferences. The study includes an evaluation phase. In the evaluation phase, the program will be tested among nurses working in general hospitals and adults with chronic diseases living in the community. Outcomes related to shared decision-making will be assessed at baseline, immediately after the 4-week program, and 1 month later. The study is expected to improve shared decision-making competence, experience, and preparedness among both nurses and patients.

Who can participate

Age range

19 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria for Nurse: * Registered nurses currently providing direct patient care in participating general hospitals * Able to understand the purpose and procedures of the study and provide informed consent * Able to use a computer, tablet, or smartphone to access the online program Exclusion Criteria for Nurse: * Not currently engaged in direct patient care * Unable to clearly express willingness to participate * Unable to complete the educational program or questionnaires because of technical or language limitations Inclusion Criteria for Patients: * Adults aged 19 years or older living in the community * Diagnosed with one or more chronic diseases requiring ongoing management, including but not limited to hypertension, diabetes mellitus, dyslipidemia, arthritis, chronic respiratory disease, or cardiovascular disease, with at least 3 months elapsed since diagnosis * Able to understand the purpose and procedures of the study and provide informed consent * Able to read and respond to survey questions * Able to use a computer, tablet, or smartphone to access the online program Exclusion Criteria for Patients: * Cognitive impairment or communication problems that make participation difficult * Unable to complete the educational program or questionnaires because of technical or language limitations

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in nurses' shared decision-making competence

Timeframe: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment

Change in patients' shared decision-making experience

Timeframe: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment

Trial details

NCT IDNCT07589673

SponsorChungnam National University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-10

Contact for this trial

Geunyoung Lee

+82 42-580-8407 lgy2513@gmail.com

View on ClinicalTrials.gov More Chronic Disease trials

Plain-language summary

Who can participate

Age range

19 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in nurses' shared decision-making competence

Timeframe: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment

Change in patients' shared decision-making experience

Timeframe: Baseline, immediately after the 4-week intervention, and 1 month after the first post-intervention assessment